Aaron Dodd
15Patents
4h-index
5Co-inventors
45Inventor score
Filing activity: Apr 23, 2010 → Dec 22, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8734847B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 6 | Active |
| US9095496B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 6 | Active |
| US9089471B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 5 | Active |
| US8735450B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 4 | Active |
| US8992982B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 2 | Active |
| US9017721B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US9186328B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US8999387B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US9180096B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US8679544B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US9173854B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 2 | Active |
| US9849111B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 1 | Active |
| US9522135B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 1 | Active |
| US9180095B2 | Formulation of diclofenac | Emerging Cross-Sectional Technologies | 0 | Active |
| US10172828B2 | Formulation of indomethacin | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.